Technical Assistance Webinar: Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Clinical High Risk for Psychosis Clinical Trial Network (U01 Clinical Trial Required)

Technical Assistance Webinar: Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Clinical High Risk for Psychosis Clinical Trial Network (U01 Clinical Trial Required) August 9, 2023 12:00–1:00 p.m. ET https://www.nimh.nih.gov/news/events/announcements/technical-assistance-webinar-accelerating-medicines-partnershipr-schizophrenia-ampr-scz-clinical-high-risk-for-psychosis-clinical-trial-network-u01 A technical assistance webinar will be held for prospective applicants of the following Notice of Funding Opportunity (NOFO): Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Clinical High Risk for Psychosis Clinical Trial Network (U01 Clinical Trial Required) . National Institute of Mental Health staff will be available to answer questions related to this NOFO. Prospective applicants can participate in the webinar and are encouraged to submit their questions or comments to the Agency Contacts listed in Section VII of this NOFO one week before the webinar. Participation in the webinar is neither required nor necessary for a successful application. A recording of the webinar will be available afterward. The purpose of this NOFO is to support one clinical trial network to evaluate biological, digital, cognitive, and clinical outcome measures in individuals at clinical high risk (CHR) for psychosis in Proof of Principle (PoP) trial(s) using a pharmacological intervention. No registration is required for this event. https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-24-150.html